04/03/2003 - 21:00

Devil's apple drug under further investigation

04/03/2003 - 21:00

Bookmark

Save articles for future reference.

Solbec Pharmaceuticals is continuing its investigation into the behaviour of its lead cancer product, developed from elements found in weed colloquially known as ‘Devil’s Apple’. Results so far suggest the drug, SBP002, may be applicable in palliative care.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options